When demands soars for prescription pharmaceuticals and supply falls short, drug pirates get to work. The bad actors manufacture and package fake drugs to look just like the legitimate brand-name medication. And many times, these counterfeits make their way into legitimate supply chains. Counterfeit versions of Novo Nordisk’s diabetes drug Ozempic pose severe risks to […]

Florida marks a milestone as the FDA authorizes the state to import prescription drugs from Canada to alleviate high drug prices. This decision, resulting from bipartisan discussions and executive orders, grants Florida a two-year period to implement its drug importation program, potentially saving the state up to $183 million in the first year. However, obstacles […]

Effective August 25, 2023: FDA issues new compliance policies to help supply chain stakeholders attain enhanced traceability under DSCSA. FDA recognizes that additional time beyond November 27, 2023 is necessary to “stabilize and be fully interoperable for accurate, secure, and timely electronic data exchange.” FDA is issuing this compliance policy to provide additional time, beyond […]

Lexington, MA, August 28, 2023 – Gateway Checker, the industry’s leading GS1-certified conformance testing service, today announced the introduction of the Gateway Certification program. A “Gateway CertifiedTM” drug transaction report enables organizations to be confident that they are compliant, interoperable, and fully conform to industry and regulatory requirements. In November, all pharmaceutical trading partners will […]